Schonfeld Strategic Advisors LLC Trevena Inc Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $58,426 - $90,040	-40,018 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $43,704 - $72,347	24,692 Added 161.11%	40,018 $72,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $32,644 - $49,962	15,326 New	15,326 $33,000
Q1 2018 May 15, 2018	SELL	$1.51 - $2.06 $226,500 - $309,000	-150,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.4 - $2.6 $350,000 - $650,000	-250,000 Reduced 62.5%	150,000 $240,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $888,000 - $1.12 Million	400,000	400,000 $1.02 Million

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.